Home > Insider Trading > Filing (0000313143-13-000165)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1497881	P Michael Kelly	400 Wood Road Braintree MA 02184	President, Global Markets	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-13	1,400	$27.49	12,737	No	4	M	Direct
Common Stock	Disposition	2013-09-13	1,400	$40.36	11,337	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-09-13	1,400	$40.36	1,400	$27.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
51,340	2011-07-28	2017-07-28	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$30.67	2012-10-25	2018-10-25	37,326	37,326	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$39.06	2013-10-24	2019-10-24	39,344	39,344	Direct
Common Stock	Performance Shares	$0.00	2027-03-31	2017-12-31	25,000	25,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-10-25	37,326	37,326	Direct
2019-10-24	39,344	39,344	Direct
2017-12-31	25,000	25,000	Direct

Footnotes

Pursuant to a 10b5-1 Plan.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).